1. Home
  2. STOK vs TRLV Comparison

STOK vs TRLV Comparison

Compare STOK & TRLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

N/A

Current Price

$26.01

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Trulieve Cannabis Corp. Subordinate Voting Shares

TRLV

Trulieve Cannabis Corp. Subordinate Voting Shares

N/A

Current Price

$10.89

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STOK
TRLV
Founded
2014
1940
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
STOK
TRLV
Price
$26.01
$10.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
7
Target Price
★ $46.46
$18.18
AVG Volume (30 Days)
638.1K
★ 1.7M
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 92.73
26.58
EPS
N/A
★ N/A
Revenue
$184,420,000.00
★ $1,181,180,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$39.98
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 404.50
N/A
52 Week Low
$20.32
$7.82
52 Week High
$40.22
$12.93

Technical Indicators

Market Signals
Indicator
STOK
TRLV
Relative Strength Index (RSI) 38.05 46.29
Support Level $25.21 $10.71
Resistance Level $33.92 $12.85
Average True Range (ATR) 1.15 0.72
MACD -0.17 -0.15
Stochastic Oscillator 36.31 34.07

Price Performance

Historical Comparison
STOK
TRLV

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About TRLV Trulieve Cannabis Corp. Subordinate Voting Shares

Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.

Share on Social Networks: